Is there a future for SGLT2 therapy to treat kidney failure in US Veterans living with autosomal dominant polycystic kidney disease?

Abstract:A patient voice piece discussing the future of SGLT2 therapy to treat kidney failure in US Veterans living with autosomal dominant polycystic kidney disease.

Epidemiology and burden of focal segmental glomerulosclerosis among United States Veterans: An analysis of Veteran's Affairs data

Abstract:Introduction: Focal segmental glomerulosclerosis (FSGS) is a rare glomerular disease that can lead to reduced kidney function and kidney failure (KF). The objective of …

Associations between abrupt transition, dialysis-requiring AKI, and early mortality in ESKD among U.S. Veterans

Abstract: BACKGROUND: Mortality is high within the first few months of starting chronic dialysis. Pre-ESKD trajectory of kidney function has been shown to be predictive of early …

Dialysis Provider and Outcomes among United States Veterans Who Transition to Dialysis

Abstract: Background and objectives: Veterans with ESKD initiate dialysis under the Veterans Health Administration (VHA), an integrated health system, or are outsourced to non-VHA …